Literature DB >> 21821176

Xpert MTB/RIF test for tuberculosis.

Grant Theron, Jonny Peter, Keertan Dheda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21821176     DOI： 10.1016/S0140-6736(11)61242-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

Authors:  Grant Theron; Anil Pooran; Jonny Peter; Richard van Zyl-Smit; Hridesh Kumar Mishra; Richard Meldau; Greg Calligaro; Brian Allwood; Surendra Kumar Sharma; Rod Dawson; Keertan Dheda
Journal:  Eur Respir J       Date:  2011-11-10       Impact factor: 16.671

Review 2.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Ian Schiller; David J Horne; Madhukar Pai; Catharina C Boehme; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2014-01-21

3.  The role of Xpert MTB/RIF assay in the diagnosis of tubercular spondylodiscitis.

Authors:  Justin Arockiaraj; Joy S Michael; Rohit Amritanand; Kenny Samuel David; Venkatesh Krishnan
Journal:  Eur Spine J       Date:  2017-04-08       Impact factor: 3.134

4.  Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial.

Authors:  Jonathan G Peter; Grant Theron; Anil Pooran; Johnson Thomas; Mellissa Pascoe; Keertan Dheda
Journal:  Lancet Respir Med       Date:  2013-07-19       Impact factor: 30.700

5.  Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.

Authors:  Jonny Peter; Grant Theron; Duncan Chanda; Petra Clowes; Andrea Rachow; Maia Lesosky; Michael Hoelscher; Peter Mwaba; Alex Pym; Keertan Dheda
Journal:  BMC Infect Dis       Date:  2015-07-09       Impact factor: 3.090

6.  Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?

Authors:  Jonathan G Peter; Grant Theron; Keertan Dheda
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.